Skip to main content

OMERS ADMINISTRATION Corp

Source: SEC Form 13F · as of Mar 2026

OMERS ADMINISTRATION Corp holds 50 biotech & pharma companies tracked by BioSniper, totaling $190.0M in value as of Mar 2026 (SEC Form 13F).

Companies held

50

Total value held

$190.0M

BioSniper AIPage context preserved

Prepared research question

What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
GILDGILEAD SCIENCES, INC.1,163,062$162.1M
REGNREGENERON PHARMACEUTICALS, INC.8,179$6.3M
INCYIncyte Corp.41,083$3.9M
EXELEXELIXIS, INC.88,362$3.8M
JAZZJazz Pharmaceuticals plc8,092$1.5M
ALNYALNYLAM PHARMACEUTICALS, INC.4,517$1.5M
STOKStoke Therapeutics, Inc.41,500$1.4M
ACADACADIA PHARMACEUTICALS INC33,500$746K
MRNAModerna, Inc.13,458$684K
KNSAKiniksa Pharmaceuticals International, plc13,100$631K
OGNOrganon & Co.71,334$427K
RDYDR REDDYS LABORATORIES LTD30,000$416K
BMRNBIOMARIN PHARMACEUTICAL INC6,767$382K
INSMINSMED Inc2,204$360K
CBIOCRESCENT BIOPHARMA, INC.17,800$327K
CTMXCytomX Therapeutics, Inc.62,400$293K
RLMDRELMADA THERAPEUTICS, INC.41,600$290K
APGEApogee Therapeutics, Inc.3,400$286K
XFORX4 Pharmaceuticals, Inc57,300$237K
ASMBASSEMBLY BIOSCIENCES, INC.8,100$225K
OVIDOvid Therapeutics Inc.100,100$222K
STROSUTRO BIOPHARMA, INC.8,700$217K
SGMTSagimet Biosciences Inc.41,100$215K
CNTXContext Therapeutics Inc.80,600$211K
IRDOpus Genetics, Inc.41,600$189K
IMUXIMMUNIC, INC.168,300$187K
IMMXImmix Biopharma, Inc.20,400$186K
ZURAZura Bio Ltd29,800$177K
AVTXAvalo Therapeutics, Inc.11,800$176K
OCGNOcugen, Inc.96,500$175K
LCTXLineage Cell Therapeutics, Inc.109,000$172K
LXRXLEXICON PHARMACEUTICALS, INC.106,800$167K
CCCCC4 Therapeutics, Inc.59,700$157K
ALXOALX ONCOLOGY HOLDINGS INC75,000$150K
CRBPCorbus Pharmaceuticals Holdings, Inc.15,200$143K
IVVDInvivyd, Inc.106,900$139K
BDTXBlack Diamond Therapeutics, Inc.62,800$134K
PROKPROKIDNEY CORP.67,900$122K
AGENAGENUS INC34,700$116K
CLYMClimb Bio, Inc.16,700$114K
ELTXElicio Therapeutics, Inc.10,700$114K
SABSSAB BIOTHERAPEUTICS, INC.29,700$114K
PRLDPrelude Therapeutics Inc32,700$112K
ZNTLZentalis Pharmaceuticals, Inc.47,700$112K
CNTNCanton Strategic Holdings, Inc.30,600$100K
SPROSpero Therapeutics, Inc.39,400$92K
GALTGALECTIN THERAPEUTICS INC24,100$67K
ORMPORAMED PHARMACEUTICALS INC.18,400$63K
ANTXAN2 Therapeutics, Inc.15,800$54K
WHWKWhitehawk Therapeutics, Inc.11,500$40K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.